We strive to provide patients and customers with new diagnostic technology: Science-based, accurate, reliable, early, and ultrafast.
At Kidod, we are committed to advancing scientific innovation in early-stage disease detection. With over two decades of expertise in In-Vitro Diagnostics (IVD) and healthcare software development, we continuously pursue novel applications grounded in rigorous research and translational science.
Our proprietary solution offers a paradigm shift in cancer diagnostics by detecting polyamine-based biomarkers through a rapid, non-invasive saliva or urine test. This approach enables earlier intervention, improved patient outcomes, and the potential to transform global standards in cancer screening and monitoring.
Our vision is to develop an IVD device that would be one point of care diagnostic: one device that will diagnose multiple diseases in early stages using one sample.
This portable diagnostic solution is designed for global impact — expanding access to advanced medical diagnostics in remote regions and underserved communities around the world.
We focus on detecting various diseases by using one single test. As saliva tests will enable the diagnosis of cancer, respiratory diseases, oral diseases, and more. We are setting up clinical studies and research globally for this goal.
Since 2002, our journey has been defined by perseverance, innovation, and impact. With over 20 years of experience, we have grown into a leading developer and manufacturer of In-Vitro Diagnostics (IVD) technologies.
From day one, our commitment to research and innovation has remained the same. As Kidod, we are driven by a mission to create revolutionary diagnostic solutions that advance global healthcare, save lives, and improve patients’ quality of life.